Ro vs Hims for GLP-1 Weight Loss: Which Is Better in 2026?
Two of the biggest telehealth platforms now offer branded Wegovy and GLP-1 programs. We compare Ro and Hims on pricing, medications, insurance, clinical support, and what actually changed after the Novo Nordisk lawsuit.
Summarize this article with
Ro is the better choice if you have insurance (Wegovy copays as low as $25/month), while Hims is cheaper for cash-pay patients ($39 first month, then $149/month). Both now offer branded Wegovy after Hims settled its Novo Nordisk lawsuit in March 2026. Ro accepts insurance and provides monthly clinical check-ins with nutrition counseling; Hims is strictly cash-pay with a streamlined, no-insurance process. Here's the full comparison as of April 2026.
The Quick Verdict
Comparing your options?
See every verified GLP-1 program ranked side by side on cost, safety, and care quality.
Compare all 52GLP-1 providers →Pricing: What You'll Actually Pay
| Ro | Hims | |
|---|---|---|
| Membership (1st month) | $45 | $39 |
| Membership (ongoing) | $145/mo | $149/mo |
| Wegovy pill | $149-299/mo | $149/mo+ |
| Wegovy pen (cash) | Available | Available |
| Wegovy pen (insurance) | Yes, as low as $25/mo | Not accepted |
| Zepbound | $449/mo via LillyDirect | Not listed |
| Foundayo (oral, Apr 2026) | $149-299/mo | TBD |
| Compounded semaglutide | Available in some states | Limited, clinically necessary only |
The biggest pricing difference: Ro accepts insurance. If your commercial insurance covers Wegovy, Ro's insurance concierge handles the prior authorization process for you. With a manufacturer savings card, your cost could drop to $25/month. Hims is strictly cash-pay, no insurance accepted, though FSA/HSA cards work.
For uninsured patients, pricing is close. Both offer the Wegovy pill starting around $149/month. Ro's membership is slightly cheaper ($145 vs $149/month ongoing), but Hims offers lower first-month pricing ($39 vs $45).
Every Tuesday. One email. The cheapest verified GLP-1 programs of the week.
Price drops, FDA alerts, new programs ranked, and compounded shortages, delivered Tuesday morning. No filler. Unsubscribe anytime.
No affiliate spam. No retargeting pixels. Unsubscribe in one click.
Medications Available
Both platforms expanded their medication offerings significantly in early 2026:
- •Ro offers: Wegovy pill, Wegovy pen, Ozempic, Zepbound ($449/mo via LillyDirect integration), Foundayo (starting April 6, 2026), and compounded options in select states
- •Hims offers: Wegovy pill (1.5mg, 4mg, 9mg, 25mg tablets), Wegovy pen (1.7mg, 2.4mg), Ozempic (0.5mg, 1mg, 2mg), and limited compounded semaglutide only when clinically necessary
- •Key difference: Ro has Zepbound (tirzepatide) and Foundayo (orforglipron), Hims does not appear to offer either as of April 2026
Ro launched the Wegovy pill on January 5, 2026, among the first telehealth platforms to offer it. Ro positions itself as a dedicated weight management platform, while Hims is a broader men's health platform that added GLP-1s to their existing hair loss, ED, and skincare offerings.
The Hims + Novo Nordisk Saga (Important Context)
The Hims-Novo relationship is a dramatic story that matters for understanding what you're getting today:
- •April 2025: Hims and Novo Nordisk announced a partnership to sell branded Wegovy on Hims at $599/month
- •June 2025: Novo terminated the deal after ~1 month, accusing Hims of continuing to sell compounded semaglutide made with unauthorized ingredients. Hims stock dropped 30%.
- •February 2026: Hims launched a $49/month compounded Wegovy pill copy. Novo immediately sued for patent infringement.
- •March 9, 2026: New deal reached. Novo dropped the lawsuit. Hims agreed to stop advertising compounded GLP-1s and offer branded Wegovy and Ozempic at standard prices. Compounded versions are only available when a provider deems it clinically necessary.
Editor's Top Pick
Yucca Health
$146/mo · 7.7/10 · Compounded
Online weight-loss program by Yucca Health, Inc. (Beverly Hills, CA). Two named board-certified doctors, Dr. Michael Wasef MD and Dr. Andrew Sakla DO, handle prescribing. 20,000+ patients, 4.6 stars across 1,065 verified Trustpilot reviews. Starts at $146/mo for compounded semaglutide (custom-made version, not the FDA-approved brand) on the 6-month plan. Buy-now-pay-later via Klarna, Affirm, or Afterpay spreads the upfront commitment.
Clinical Support
| Feature | Ro | Hims |
|---|---|---|
| Consultation | Free async, 24hr provider review | Online assessment |
| Ongoing support | Monthly check-ins, unlimited messaging | 24/7 provider access, quarterly reviews |
| Health coaching | Included | Not included |
| Nutrition counseling | Included | Not included |
| Exercise planning | Included | Not included |
| Lab work | Metabolic labs may be required | Not required |
| Insurance concierge | Yes, handles prior auth | N/A (no insurance) |
Ro's clinical model is more comprehensive, it's a dedicated weight management program with health coaching, nutrition, and exercise support built in, a focus they've heavily marketed since their Super Bowl 2026 campaign. Hims offers provider access and check-ins but positions the medication as the primary intervention. If you want a hands-on program that goes beyond the prescription, Ro delivers more value. If you want straightforward medication access without extras, Hims is simpler.
Not sure which GLP-1 program is right for you?
Take the 60-second quiz, we'll match you against 52 verified providers on your goals, budget, and medication preference, then surface your top 3.
Take the 60-sec QuizUser Reviews
Ro has a 3.7/5 rating on Trustpilot from 3,131 reviews. Common positives: convenience, provider communication, significant weight loss. Common negatives: customer service frustrations, delivery delays, and confusion about membership ($145) being separate from medication cost.
Hims has a 4.4/5 on Trustpilot from 32,000+ reviews across all products (4.1/5 for weight loss specifically). Positives: effective medication, easy process. Negatives: shipping delays, prescription refill delays, and prepaid no-refund policy frustrating users who want to cancel.
Who Should Choose Ro
- •You have commercial insurance that might cover Wegovy, Ro handles prior authorization for you
- •You want comprehensive clinical support (coaching, nutrition, exercise planning)
- •You want access to Zepbound or the new Foundayo pill alongside Wegovy
- •You prefer a platform focused entirely on weight management
Who Should Choose Hims
- •You're paying cash and want the lowest entry point ($39 first month)
- •You want a simple process, no insurance paperwork, no lab requirements
- •You already use Hims for other health products and want one platform
- •You want branded Wegovy pill or pen without comprehensive program extras
Our Ranking
In our provider rankings, Ro scores 8.6/10 (ranked #5) and Hims is ranked #32 in our GLP-1 provider rankings. Ro's higher score reflects its insurance acceptance, broader medication options (Zepbound, Foundayo), and more comprehensive clinical support model. Both are legitimate platforms backed by licensed US physicians.
Not sure which is right for you? Take our match quiz to get personalized recommendations based on your budget, insurance status, and preferences, or use the cost calculator to estimate what you'd actually pay.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any medication. Information is current as of the publication date but may change.
Affiliate Disclosure: Some links in this article are affiliate links. We may earn a commission if you sign up through our links, at no extra cost to you.
Done comparing? Our Top Pick is Yucca Health
Our featured pick, scored 7.7/10 by our methodology, at $146/mo all-in. Not sure it's the one for you? The 60-second quiz matches you to your budget and medication.
Featured affiliate pick, we may earn a commission · scores set by our methodology, not payment
Compare every GLP-1 program in one place
See all 52 verified providers ranked side by side on price, medication, and our independent score, or jump straight to the cheapest verified prices.
Ozempic vs Wegovy (2026): Same Drug, $1,028 vs $1,349 List, Here's Which You Need
Cost & InsuranceGLP-1 Cost 2026: Wegovy, Zepbound & Ozempic Prices ($25–$1,350/mo)
News & PipelineMedicare GLP-1 Coverage: Everything Changing in July 2026
Keep exploring
- →Provider Rankings
- →Cheapest Providers
- →Take the Match Quiz
- →Weight Loss Predictor
- →Full Cost Guide
- →Cost Calculator
What the doctors say
Verbatim, independently sourced statements from named physicians and medical bodies, real clinicians quoted with their sources, not a single paid reviewer. General clinical context, not an endorsement of any provider.
“We now have medicines that not only reduce heart attacks, strokes, and peripheral arterial disease, but also simultaneously lead to meaningful weight loss – which in turn lowers the risk of many weight-related conditions. These treatments also improve patients' quality of life in a meaningful way, making this a genuine win–win.”
“It's the first time that we have seen this magnitude of weight loss compared to current medications on the market for obesity. It's 1.5 to 2.5 times more effective than currently available drugs.”
“Thanks to the latest advancements in obesity management medications, more physicians and patients are witnessing significant weight reduction beyond what they have seen before. The SURMOUNT-5 head-to-head results demonstrated tirzepatide led to greater weight reduction compared to semaglutide, providing further evidence to support tirzepatide as an effective option for obesity.”
Quotes are general medical commentary about GLP-1 medications, independently sourced and not solicited by GLP-1 Picks. They are not an endorsement of any provider, our provider scores are set solely by our published methodology.